Rabeprazole sodium: Clinical Trials

6 completed. 6 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	6	Completed 6
Phase 2	1	Completed 1

Follow Rabeprazole sodium: new trials by email Literature Review of Rabeprazole sodium trials Research Report on Rabeprazole sodium

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood BI 1810631 - trial formulation 1 (TF1), BI 1810631 - new formulation (NF), Rabeprazole sodium - Healthy	Phase 1	Completed	Boehringer Ingelheim	13	2022-06-23	2025-11-04
A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules TNP-2198, Rabeprazole Sodium, Amoxicillin - Helicobacter Pylori Infection	Phase 1 / Phase 2	Completed	TenNor Therapeutics (Suzhou) Limited	40	2021-09-27	2023-11-22
A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) Rabeprazole sodium - Gastroesophageal Reflux	Phase 1	Completed	Janssen Research & Development, LLC	69	2009-07-01	2013-04-29
A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers rabeprazole sodium - Gastroesophageal Reflux	Phase 1	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	36	2008-08-01	2014-05-28
A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive Rabeprazole sodium - GERD	Phase 1	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	31	2008-03-01	2011-01-10
A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole rabeprazole sodium - GERD	Phase 1	Completed	Janssen-Ortho Inc., Canada	37	2005-10-01	2012-12-10

Conditions studied

Gastroesophageal Reflux (4)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Boehringer Ingelheim (1)  ·  Janssen Research & Development, LLC (1)  ·  Janssen-Ortho Inc., Canada (1)  ·  TenNor Therapeutics (Suzhou) Limited (1)

Countries

Germany (2)  ·  United States (2)  ·  China (1)  ·  Poland (1)  ·  United Kingdom (1)

Results publications

PMID 17116123, PMID 27129014, PMID 38359854